Pharma Stocks
-
SpyGlass Pharma Shares Rise in Nasdaq Debut
Market Closed – Nasdaq 04:23:35 2026-02-06 pm EST 5-day change 1st Jan Change 23,031.21 PTS +2.18% -1.84% -0.91% Published on…
Read More » -
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged…
Read More » -
DOCS Q4 Deep Dive: AI Momentum Overshadowed by Pharma Budget Delays and Cautious Guidance
Medical professional network Doximity (NYSE: DOCS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.8% year…
Read More » -
Stock Market Today LIVE | Feb 6: Sensex trades 400 pts higher from day’s low, Nifty 50 tests 25600; Nifty FMCG up over 1%
Stock Market Today: Domestic equity benchmarks Sensex and Nifty 50 opened in the red on Friday. The BSE Sensex declined…
Read More » -
Here’s Why We Think Emcure Pharmaceuticals (NSE:EMCURE) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering ‘the next big thing’, even if that means buying ‘story stocks’…
Read More » -
12 Health Care Stocks Moving In Thursday’s Intraday Session – AIM ImmunoTech (AMEX:AIM), Akanda (NASDAQ:AKAN)
Gainers Estrella Immunopharma (NASDAQ:ESLA) shares moved upwards by 34.4% to $1.4 during Thursday’s regular session. The market value of their…
Read More » -
LB Pharmaceuticals Announces $100.0 Million Private Placement
LB Pharmaceuticals Inc NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq:…
Read More » -
A Tale of Two Pharma Stocks: Stability Versus Speculation
In today’s complex investment landscape, a fundamental choice confronts investors: the steady promise of established giants or the explosive potential…
Read More » -
Earnings Tell The Story For Hanmi Pharm. Co., Ltd. (KRX:128940)
When close to half the companies in Korea have price-to-earnings ratios (or “P/E’s”) below 14x, you may consider Hanmi Pharm.…
Read More » -
Pharma, Specialty Units Likely to Drive Cardinal Health’s Q2 Earnings
Cardinal Health, Inc. CAH is scheduled to report second-quarter fiscal 2026 results on Feb. 05, before market open. In the…
Read More »